$CRNC

Cerence Inc. (CRNC): Results of Operations and Financial Condition

Cerence Inc. (CRNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26cerenceaipressrele.htm EX-99.1 q3fy26cerenceaipressrele Cerence AI Reports Third Quarter Results: Revenue Up 12% YoY, Connected Services Revenue Up 20% YoY; Operating Cash Flow of $20M Supports First-Ever Share Repurchase Program Headlines • Revenue of $69.6 milli

Original reporting
Published Aug 6, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CRNC
Bullish
high confidence
Mentioned
$CRNC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CRNCBullishHigh
01

Why it matters

Traders can update models using the disclosed Q3 financials, free cash flow, and the explicit Q4 revenue, margin, GAAP net income, GAAP EPS, and adjusted EBITDA ranges, while also incorporating buyback support to per-share expectations.

02

Market read

The filing combines a guidance-relevant earnings release with a new capital return program and a detailed Q4 outlook, creating a near-term catalyst for CRNC positioning.

03

What to watch

Q4 outlook notes no fixed license revenue contracts expected to be signed in the quarter, which could cap upside if investors were expecting new fixed-license momentum.

Relevance 7/10Novelty 9/10Timing: after-hours filing on Aug 6, 2026, with Q4FY26 outlook included

Background

This is an SEC Form 8-K (Item 2.02) with Cerence’s Q3FY26 results, cash-flow metrics, and a first-ever share repurchase authorization.

Company-level read

Ticker impact

$CRNCBullishHigh confidence
Context

Cerence reported Q3FY26 revenue of $69.6M, adjusted EBITDA of $13.5M (+50% YoY), and authorized a first $30M share repurchase program.

Expected impact

Likely positive near-term bias, with follow-through dependent on whether Q4 guidance ($61M-$65M revenue, GAAP EPS $0.02-$0.10) is viewed as credible.

Evidence & confidence

The filing includes specific Q3 results versus guidance, free cash flow generation, and a concrete repurchase authorization size and duration, all of which are actionable for positioning.

Market effects

Supports sentiment for automotive conversational AI and connected-services monetization, especially where cash generation enables buybacks.

Primarily US-listed small-cap tech/auto-AI sentiment; limited direct regional spillover beyond investor base.

Automaker customer wins (e.g., Stellantis) reinforce global OEM adoption narrative, but impact is company-specific.

Counterpoint

Revenue growth is partly timing-driven (fixed license execution), while professional services revenue declined, so the quality of growth may be questioned.

Key entities

  • Cerence Inc.

    NASDAQ-listed conversational AI company reporting Q3FY26 results and authorizing a first $30M share repurchase program.

  • Stellantis

    Named as the recipient of a multi-brand Cerence xUI award, cited as an AI platform adoption milestone.

  • Mobile Work Agent

    Cited as securing its first customer win, supporting the company’s agentic AI adoption narrative.

Related articles

$RGAMed

REINSURANCE GROUP OF AMERICA INC (RGA): Results of Operations and Financial Condition

REINSURANCE GROUP OF AMERICA INC (RGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 qfs2q26.htm EX-99.2 Document Exhibit 99.2 Quarterly Financial Supplement Second Quarter 2026 (Unaudited) World Headquarters Internet Address Contacts 16600 Swingley Ridge Road www.rgare.com Laura Cockrill Chesterfield, Missouri 63017 U.S.A. EVP, Chief Financial Officer

$PBYIMed

PUMA BIOTECHNOLOGY, INC. (PBYI): Results of Operations and Financial Condition

PUMA BIOTECHNOLOGY, INC. (PBYI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973970.htm EXHIBIT 99.1 ex_973970.htm Exhibit 99.1 News Release Puma Biotechnology Reports Second Quarter 2026 Financial Results Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNX LOS ANGELES, Calif., Aug. 6, 2026 - Puma Biotechnology,

$GAINMed

GLADSTONE INVESTMENT CORPORATION\DE (GAIN): Results of Operations and Financial Condition

GLADSTONE INVESTMENT CORPORATION\DE (GAIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gain63026er8-kex991x8626.htm EX-99.1 Document Gladstone Investment Corporation Reports Financial Results for its First Quarter Ended June 30, 2026 MCLEAN, VA, August 6, 2026: Gladstone Investment Corporation (Nasdaq: GAIN) (the "Company") today announced earnings for it

$KRMNHighAI 9/10

Karman Holdings Inc. (KRMN): Results of Operations and Financial Condition

Karman Holdings Inc. (KRMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 krmn-ex99_1.htm EX-99.1 EX-99.1 Ex. 99.1 Karman Space & Defense Reports Second Quarter Fiscal Year 2026 Financial Results HUNTINGTON BEACH, Calif., August 6, 2026 – Karman Space & Defense (“Karman”, “Karman Holdings, Inc.” or “the Company”) (NYSE: KRMN), a leader in the